Search Results - "Moffett, John R"

Refine Results
  1. 1

    Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis-Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain Synthetases by Moffett, John R, Puthillathu, Narayanan, Vengilote, Ranjini, Jaworski, Diane M, Namboodiri, Aryan M

    Published in Frontiers in physiology (12-11-2020)
    “…Acetate is a major end product of bacterial fermentation of fiber in the gut. Acetate, whether derived from the diet or from fermentation in the colon, has…”
    Get full text
    Journal Article
  2. 2

    The end of the road for the tryptophan depletion concept in pregnancy and infection by Badawy, Abdulla A-B, Namboodiri, Aryan M A, Moffett, John R

    Published in Clinical science (1979) (01-08-2016)
    “…We hypothesize that: (1) L-tryptophan (Trp) is greatly utilized and not depleted in pregnancy; (2) fetal tolerance is achieved in part through…”
    Get more information
    Journal Article
  3. 3

    Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis - Part 2: Acetate and ACSS2 in Health and Disease by Moffett, John R, Puthillathu, Narayanan, Vengilote, Ranjini, Jaworski, Diane M, Namboodiri, Aryan M

    Published in Frontiers in physiology (12-11-2020)
    “…Acetate, the shortest chain fatty acid, has been implicated in providing health benefits whether it is derived from the diet or is generated from microbial…”
    Get full text
    Journal Article
  4. 4

    Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD + Synthesis During Inflammation and Infection by Moffett, John R, Arun, Peethambaran, Puthillathu, Narayanan, Vengilote, Ranjini, Ives, John A, Badawy, Abdulla A-B, Namboodiri, Aryan M

    Published in Frontiers in immunology (21-02-2020)
    “…Quinolinate (Quin) is a classic example of a biochemical double-edged sword, acting as both essential metabolite and potent neurotoxin. Quin is an important…”
    Get full text
    Journal Article
  5. 5

    Tryptophan and the immune response by Moffett, John R, Namboodiri, MA Aryan

    Published in Immunology and cell biology (01-08-2003)
    “…The immune system continuously modulates the balance between responsiveness to pathogens and tolerance to non‐harmful antigens. The mechanisms that mediate…”
    Get full text
    Journal Article
  6. 6

    Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure by Krishnan, Jishnu K S, Moffett, John R, Puthillathu, Narayanan, Johnson, Erik A, Namboodiri, Aryan M

    Published in Frontiers in pharmacology (02-10-2024)
    “…We have shown that briefly inhaled isoflurane rapidly halts convulsions and protects the central nervous system (CNS) from organophosphate-induced neuronal…”
    Get full text
    Journal Article
  7. 7

    Brief isoflurane administration as an adjunct treatment to control organophosphate-induced convulsions and neuropathology by Puthillathu, Narayanan, Moffett, John R, Korotcov, Alexandru, Bosomtwi, Asamoah, Vengilote, Ranjini, Krishnan, Jishnu K S, Johnson, Erik A, Arun, Peethambaran, Namboodiri, Aryan M

    Published in Frontiers in pharmacology (05-12-2023)
    “…Organophosphate-based chemical agents (OP), including nerve agents and certain pesticides such as paraoxon, are potent acetylcholinesterase inhibitors that…”
    Get full text
    Journal Article
  8. 8

    Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia by Zuo, Daiying, Bzdega, Tomasz, Olszewski, Rafal T., Moffett, John R., Neale, Joseph H.

    Published in The Journal of biological chemistry (22-06-2012)
    “…The “glutamate” theory of schizophrenia emerged from the observation that phencyclidine (PCP), an open channel antagonist of the NMDA subtype of glutamate…”
    Get full text
    Journal Article
  9. 9

    N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation by Moffett, John R, Arun, Peethambaran, Ariyannur, Prasanth S, Namboodiri, Aryan M A

    Published in Frontiers in neuroenergetics (26-12-2013)
    “…N-Acetylaspartate (NAA) is employed as a non-invasive marker for neuronal health using proton magnetic resonance spectroscopy (MRS). This utility is afforded…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA by Nonaka, Takahiro, Yamada, Toshihiko, Ishimura, Tatsuhiro, Zuo, Daiying, Moffett, John R, Neale, Joseph H, Yamamoto, Tatsuo

    Published in Molecular pain (2017)
    “…N-acetylaspartylglutamate (NAAG) is the third most prevalent and widely distributed neurotransmitter in the mammalian nervous system. NAAG activates a group II…”
    Get full text
    Journal Article
  13. 13

    Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain by Ariyannur, Prasanth S., Moffett, John R., Madhavarao, Chikkathur N., Arun, Peethambaran, Vishnu, Nisha, Jacobowitz, David M., Hallows, William C., Denu, John M., Namboodiri, Aryan M.A.

    Published in Journal of comparative neurology (1911) (01-08-2010)
    “…Acetyl coenzyme A synthetase‐1 (AceCS1) catalyzes the synthesis of acetyl coenzyme A from acetate and coenzyme A and is thought to play diverse roles ranging…”
    Get full text
    Journal Article
  14. 14

    Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease by Appu, Abhilash P, Moffett, John R, Arun, Peethambaran, Moran, Sean, Nambiar, Vikram, Krishnan, Jishnu K S, Puthillathu, Narayanan, Namboodiri, Aryan M A

    Published in Frontiers in molecular neuroscience (02-06-2017)
    “…Canavan disease is caused by mutations in the gene encoding aspartoacylase (ASPA), a deacetylase that catabolizes N-acetylaspartate (NAA). The precise…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Metabolic acetate therapy for the treatment of traumatic brain injury by Arun, Peethambaran, Ariyannur, Prasanth S, Moffett, John R, Xing, Guoqiang, Hamilton, Kristen, Grunberg, Neil E, Ives, John A, Namboodiri, Aryan M A

    Published in Journal of neurotrauma (01-01-2010)
    “…Patients suffering from traumatic brain injury (TBI) have decreased markers of energy metabolism, including N-acetylaspartate (NAA) and ATP. In the nervous…”
    Get more information
    Journal Article
  17. 17

    NAAG Peptidase Inhibition in the Periaqueductal Gray and Rostral Ventromedial Medulla Reduces Flinching in the Formalin Model of Inflammation by Yamada, Toshihiko, Zuo, Daiying, Yamamoto, Tatsuo, Olszewski, Rafal T, Bzdega, Tomasz, Moffett, John R, Neale, Joseph H

    Published in Molecular pain (12-09-2012)
    “…Background: Metabotropic glutamate receptors (mGluRs) have been identified as significant analgesic targets. Systemic treatments with inhibitors of the enzymes…”
    Get full text
    Journal Article
  18. 18

    Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells by Long, Patrick M, Tighe, Scott W, Driscoll, Heather E, Moffett, John R, Namboodiri, Aryan M A, Viapiano, Mariano S, Lawler, Sean E, Jaworski, Diane M

    Published in PloS one (20-11-2013)
    “…Cancer is associated with globally hypoacetylated chromatin and considerable attention has recently been focused on epigenetic therapies. N-acetyl-L-aspartate…”
    Get full text
    Journal Article
  19. 19

    Do reductions in brain N-acetylaspartate levels contribute to the etiology of some neuropsychiatric disorders? by Ariyannur, Prasanth S., Arun, Peethambaran, Barry, Erin S., Andrews-Shigaki, Brian, Bosomtwi, Asamoah, Tang, Haiying, Selwyn, Reed, Grunberg, Neil E., Moffett, John R., Namboodiri, Aryan M.A.

    Published in Journal of neuroscience research (01-07-2013)
    “…N‐acetylaspartate (NAA) is recognized as a noninvasive diagnostic neuronal marker for a host of neuropsychiatric disorders using magnetic resonance…”
    Get full text
    Journal Article
  20. 20

    Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease by Arun, Peethambaran, Madhavarao, Chikkathur N, Moffett, John R, Hamilton, Kristen, Grunberg, Neil E, Ariyannur, Prasanth S, Gahl, William A, Anikster, Yair, Mog, Steven, Hallows, William C, Denu, John M, Namboodiri, Aryan M. A

    Published in Journal of inherited metabolic disease (01-06-2010)
    “…Genetic mutations that severely diminish the activity of aspartoacylase (ASPA) result in the fatal brain dysmyelinating disorder, Canavan disease. There is no…”
    Get full text
    Journal Article